This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
1 Jun 2012

Eli Lilly Opens Diabetes Research Center in China

The diabetes-specific R&D center, holding 150 scientists and staff when full, is part of a trend in drug development.

Eli Lilly and Co. opened a drug research center this week in China. The center gives a new twist to the growing approach of personalizing medicine for the patient.

 

The Shanghai center focuses on discovering diabetes medicines geared specifically to the Chinese.

 

Lilly is creating what will be its second-largest R&D center abroad because it gives greater entree to the huge Chinese market (China is the world’s most populous country, with 1.3 billion people) and responds to the spread of diabetes there (nearly 10percent of Chinese adults have it).

 

The diabetes-specific R&D center, holding 150 scientists and staff when full, is part of a trend in drug development,

Related News